Canbiola, Inc. (CANB) financial statements (2020 and earlier)

Company profile

Business Address 960 SOUTH BROADWAY, SUITE 120
HICKSVILLE, NY 11801
State of Incorp. FL
Fiscal Year End December 31
SIC 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 808230
Cash and cash equivalents 808230
Receivables 3975 
Inventory, net of allowances, customer advances and progress billings 8710 
Inventory 8710 
Prepaid expense 210  
Other undisclosed current assets  7116
Total current assets: 1,14415746
Noncurrent Assets
Property, plant and equipment 6052 
Long-term investments and receivables 1939 
Accounts and financing receivable, after allowance for credit loss 1939 
Intangible assets, net (including goodwill) 561025
Goodwill 56  
Intangible assets, net (excluding goodwill)  1025
Prepaid expense 2,366  
Deposits noncurrent assets 49  
Other undisclosed noncurrent assets (0)(39)65
Total noncurrent assets: 2,5496291
TOTAL ASSETS: 3,694219137
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 186  
Accounts payable 73  
Accrued liabilities 44  
Employee-related liabilities 69  
Other undisclosed current liabilities  1,949652
Total current liabilities: 1861,949652
Noncurrent Liabilities
Other undisclosed liabilities 19  
Total liabilities: 2051,949652
Stockholders' equity
Stockholders' equity attributable to parent, including: 3,489(1,730)(515)
Preferred stock  244104
Common stock 16,62512,52411,890
Additional paid in capital 873150 
Accumulated deficit (18,769)(14,647)(12,508)
Other undisclosed stockholders' equity attributable to parent 4,7600 
Total stockholders' equity: 3,489(1,730)(515)
TOTAL LIABILITIES AND EQUITY: 3,694219137

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
Revenues 66912395
Revenue, net123 
Cost of revenue
(Cost of Goods and Services Sold)
 (406)(44) 
Gross profit: 2637895
Operating expenses (3,679)(836)(507)
Other operating income, net  13463
Operating loss: (3,416)(623)(349)
Nonoperating income
(Investment Income, Nonoperating)
 1031
Interest and debt expense (264)27956
Loss from continuing operations before equity method investments, income taxes: (3,669)(341)(291)
Other undisclosed loss from continuing operations before income taxes (443)  
Loss from continuing operations before income taxes: (4,112)(341)(291)
Income tax benefit  749233
Net income (loss): (4,112)408(59)
Other undisclosed net loss attributable to parent  (2,547)(606)
Net loss available to common stockholders, diluted: (4,112)(2,140)(665)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
Net income (loss): (4,112)408(59)
Other comprehensive loss (4,112)(2,140) 
Comprehensive loss, net of tax, attributable to parent: (8,225)(1,732)(59)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: